Latest filing published 20 Jun 2024 for Ajanta Pharma Limited, €3.4M.
Filing timeline
BuySaleInsider track record
Ravi P Agrawal, trustee Ravi Agrawal Trust: trading record in brief
Ravi P Agrawal, trustee Ravi Agrawal Trust is a declared insider of Ajanta Pharma Limited (board member), with filings sourced from SEBI (PIT + SAST). In total, 33 filings cover trades dated from 4 June 2021 to 19 June 2024.
The open-market record consists of 1 sale worth €1.1M, with no purchase.
On 20 June 2024 came the latest disclosure, a transaction for €3.4M in Ajanta Pharma Limited. Filings reach the SEBI (PIT + SAST) feed a median of 1 day after the trade. That lag is the time during which only the insider knows about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Ravi P Agrawal, trustee Ravi Agrawal Trust
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 110,037 shares@ ₹2,770.0076.6% of flowEquity SharesSEBI:6a6e007af9472a79d7b38911e5ff824f6129e9f6
- 33,682 shares@ ₹2,770.0023.4% of flowEquity SharesSEBI:7d8fc221a0b2b34f84aff9ac332b7fa6463b39a8
- 58,036 shares@ ₹1,731.500.6% of flowEquity SharesSEBI:8141c4ad8e477ce219ff7d5ae8026d5d2d5da1ee
- 83,304 shares@ ₹1,717.750.9% of flowEquity SharesSEBI:19519620e21679fdc82d6996c3fa907e4c2a83da
- 518,001 shares@ ₹1,766.755.5% of flowEquity SharesSEBI:0c3e1c17fa0808b4a1cde42d21b68715e2da85c8
- 117,500 shares@ ₹1,478.601.0% of flowEquity SharesSEBI:90d39050ae9538d8f0a06f74c1a1badd5aabf487
- 190,250 shares@ ₹1,509.951.7% of flowEquity SharesSEBI:ba874241ee22d7abc6e8869ad1e4f691d299ccb1
- 303,698 shares@ ₹1,425.002.6% of flowEquity SharesSEBI:5e8fed11aac484a445ca783765a87ecab25ae91d
- 85,102 shares@ ₹1,163.30570.6% of flowEquity SharesSEBI:86dac65d8357e8209ce615a28c92ecac8917e69b
- 1,638,887 shares@ ₹1,160.1011.6% of flowEquity SharesSEBI:ef6590547637e89d25124fccdff26b053594c79f
- 156,906 shares@ ₹2,550.002.5% of flowEquity SharesSEBI:cfa1155972a6005310e2f8a4e5e2b56d43ab0781
- 175,000 shares@ ₹2,094.202.3% of flowEquity SharesSEBI:df8a82a1bc31747134318df1b312deddd065401d
- 100,000 shares@ ₹2,170.651.4% of flowEquity SharesSEBI:93e23e77948e3ca38c23800245fb387520c57382
- 250,000 shares@ ₹2,278.103.6% of flowEquity SharesSEBI:6aae3313e0d7d97972300c0c5e992164df21dccb
- 358,000 shares@ ₹2,301.205.1% of flowEquity SharesSEBI:b725f2c72af109e163873c935d19cebbdc75dfd8
- 420,000 shares@ ₹2,180.705.7% of flowEquity SharesSEBI:d9e578bcce045893b3cd86df3e81a53fd0b67560
- 100,000 shares@ ₹2,217.401.4% of flowEquity SharesSEBI:3b516fa01be539bc5f1fc9f9bb4471f8024024fa
- 279,200 shares@ ₹2,137.053.7% of flowEquity SharesSEBI:6edcf94e581c3a31dd6628dd785ebcb99e2eecb3
- 262,450 shares@ ₹2,143.503.5% of flowEquity SharesSEBI:e81a5ff74f0a65be84df4c9450d3b8bcf85b2220
- 685,000 shares@ ₹2,181.209.3% of flowEquity SharesSEBI:07b322caea0dee0ec6ecb007ce06cd6320eab31e
- 684,360 shares@ ₹2,181.209.2% of flowEquity SharesSEBI:2c1196828f0ada25cc9bbad7a6f65bafae1bcde3
- 690,000 shares@ ₹2,239.200.46% mcap9.6% of flowEquity SharesSEBI:49ecd7444a76c0e32829ca1f0a01d55764ea00c4
- 130,000 shares@ ₹2,295.800.089% mcap1.8% of flowEquity SharesSEBI:f44e5e4295bbe82e67c5585a4407916040c6934d
- 100,000 shares@ ₹2,295.800.068% mcap4.8% of flowEquity SharesSEBI:f1bb50f72293304a3647d7b7e3215b563b503da0
- 100,000 shares@ ₹2,295.800.068% mcap1.4% of flowEquity SharesSEBI:bec0828ebd8de8c1d02324b94b17e4dcbb410fd7
25 of 33 declarations